Somebody else pays first: management describes counterparties putting their own money down ahead of delivery
The model's full reasoning — Q3 2018 call → NOWe need answer YES/NO. Need analyze transcript. Question: does management describe that counterparties are putting their own money/resources at risk before receiving what they are paying for — paying, depositing, reserving, funding, committing capital in advance of delivery — and present as actually happening now? Need look for any mention of prepayments, deposits, upfront fees, milestone payments, etc. Transcript: Amgen earnings call. They discuss revenue, product sales, launches, biosimilars, pipeline. No mention of customers paying in advance. There is mention of "milestone payment received related to Aimovig partnership with Novartis" in other revenues. That is a partner/licensee paying an upfront fee? Actually milestone payment received from Novartis related to Aimovig partnership. Is that a counterparty committing capital ahead of delivery? Milestone payments are typically payments upon achievement of milestones, not necessarily in advance of delivery. But question asks "paying, depositing, reserving, funding, or committing capital in advance of delivery" — milestone payment received related to partnership could be a payment from partner for something? Need see context: "Other revenues at $394 million increased $74 million year-over-year primarily due to a milestone payment received related to our Aimovig partnership with Novartis." That is a payment from Novartis, a partner, likely for achieving a milestone (e.g., approval/launch). Is that "putting their own money at risk before they receive what they are paying for"? Milestone payments are often payments for rights or achievements, not necessarily pre-funding future delivery. The question specifically asks about counterparties pre-funding the company. A milestone payment from a partner could be considered an upfront or milestone fee in a collaboration, but is it "in advance of delivery"? The company received a milestone payment related to partnership; it's not described as for something not yet delivered. It's likely a payment triggered by a milestone already achieved, so it's not ahead of delivery. Also, it's not described as customers paying for products. It's a partnership milestone. The question says "partner or licensee paying an upfront fee, guarantee, or advance ahead of any product changing hands" — but here it's a milestone payment, not necessarily upfront.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| ROP | Roper Technologies, Inc. | Q2 2018 | 2018-07-26 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
SYM · Q3 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing real advance commitments from customers: the $11.3 billion backlog (more than doubled), strong deferred revenue on the balance sheet representing a "very significant cost float," and contracts that lock in commitments with restricted changes. Revenue is recognized on a percentage-of-completion basis during deployment, meaning payments 18 months ahead of acceptance. This is framed as an active benefit enabling confident scaling, not a routine or historical norm. They also note improved supplier terms, but the customer-side pre-funding via deferred revenue and backlog is explicitly highlighted as occurring now. This meets the criteria for counterparties committing capital ahead of delivery.
EVGO · Q2 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing the eXtend model with Pilot and GM where the customer (Pilot/GM) incurs the upfront capital expenditures for the charging infrastructure, while EVgo receives ongoing revenues from operations, maintenance, and services. This is presented as an actual, current business arrangement that provides EVgo with immediate cash flow and contracted revenues, not as a future hope or industry norm. Cathy Zoi notes the agreement exceeds IRR hurdles and provides near-term revenue, and Olga Shevorenkova explains the customer funds the build-out, enabling EVgo to generate margin as developer and operator.
BLZE · Q3 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing B2 Reserve as a capacity-based pricing program that includes premium support and free data migration, with revenue ramping in Q3. Frank notes B2 Reserve contracts are "effectively committed contracts," and Gleb calls them "committed contracts" in response to an investor question. This is presented as occurring now, with "initial ramp in demand" and "revenue increasing each month of Q3," not as a future plan or industry norm. The capacity-reservation aspect aligns with the described phenomenon of counterparties committing capital in advance.